85 related articles for article (PubMed ID: 2496716)
1. Reduction of p24 antigen levels in asymptomatic patients using twice-daily zidovudine.
Gill S; Thin N; Cordery M; Spacey B; Barlow D
AIDS; 1989 Jan; 3(1):48-9. PubMed ID: 2496716
[No Abstract] [Full Text] [Related]
2. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.
Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD
J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173
[TBL] [Abstract][Full Text] [Related]
3. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
[TBL] [Abstract][Full Text] [Related]
4. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
Reddy MM; McKinley G; Englard A; Grieco MH
J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
[TBL] [Abstract][Full Text] [Related]
5. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS.
Borghi V; De Rienzo B; Pietrosemoli P; Pecorari M; Mongiardo N; Pellegrino F; Zanchetta GP; Lami G; Squadrini F
Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304
[TBL] [Abstract][Full Text] [Related]
6. Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients.
Lange JM; de Wolf F; Mulder JW; Coutinho RA; van der Noordaa J; Goudsmit J
J Infect; 1989 Jan; 18 Suppl 1():85-91. PubMed ID: 2492586
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of virus isolation and antigen enzyme immunoassay in the detection of HIV].
Barrett PN; Dorner F; Stingl G; Heinz FX; Kunz C
Wien Klin Wochenschr; 1989 Jun; 101(13):446-7. PubMed ID: 2503943
[TBL] [Abstract][Full Text] [Related]
8. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
Stambuk D; Hawkins D; Gazzard BG
J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
Pinching AJ; Helbert M; Peddle B; Robinson D; Janes K; Gor D; Jeffries DJ; Stoneham C; Mitchell D; Kocsis AE
J Infect; 1989 Jan; 18 Suppl 1():33-40. PubMed ID: 2521663
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients].
Tamalet C; Puel J; Fleury H; Ferchal F; Agut H; Brun-Vezinet F; Botti G; Rouzioux C
Pathol Biol (Paris); 1993 Apr; 41(4):399-403. PubMed ID: 8233642
[TBL] [Abstract][Full Text] [Related]
11. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.
Merigan TC; Skowron G; Bozzette SA; Richman D; Uttamchandani R; Fischl M; Schooley R; Hirsch M; Soo W; Pettinelli C
Ann Intern Med; 1989 Feb; 110(3):189-94. PubMed ID: 2536257
[TBL] [Abstract][Full Text] [Related]
12. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine.
Jacobson MA; Abrams DI; Volberding PA; Bacchetti P; Wilber J; Chaisson RE; Crowe S; Howard W; Moss A
J Infect Dis; 1989 Jun; 159(6):1029-36. PubMed ID: 2566637
[TBL] [Abstract][Full Text] [Related]
13. Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatment.
Portegies P; Danner SA; Enting RH; Meilof J; de Wolf F; Goudsmit J
Antivir Ther; 1996 Aug; 1(3):195. PubMed ID: 11322255
[No Abstract] [Full Text] [Related]
14. Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection.
Relimpio F; Rey C; Pineda JA; Leal M; Caruz A; Sánchez-Quijano A; Lissen E
Antivir Ther; 1997 Apr; 2(2):99-104. PubMed ID: 11322281
[TBL] [Abstract][Full Text] [Related]
15. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
Mulder JW; de Wolf F; Goudsmit J; Cload PA; Coutinho RA; Fiddian AP; Schellekens PT; van der Noordaa J; Lange JM
Antiviral Res; 1990 Mar; 13(3):127-38. PubMed ID: 1972321
[TBL] [Abstract][Full Text] [Related]
16. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
17. Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
Bergdahl S; Sönnerborg A; Larsson A; Strannegard O
Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890
[No Abstract] [Full Text] [Related]
18. [Elevation of HIV-antigen concentration during administration of zidovudine].
Valencia ME; Gil A; Pintado V; Zapico RM
Med Clin (Barc); 1993 Feb; 100(6):239. PubMed ID: 8429735
[No Abstract] [Full Text] [Related]
19. Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain.
Leal M; Pineda JA; Calderón EJ; Rey C; Lissen E
Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):244-8. PubMed ID: 2496994
[TBL] [Abstract][Full Text] [Related]
20. [Decrease in human immunodeficiency virus antigen levels in the cerebrospinal fluid during zidovudine treatment in patients with AIDS].
de Gans J; Lange JM; Derix MM; de Wolf F; Ongerboer de Visser BW; Goudsmit J
Ned Tijdschr Geneeskd; 1988 Sep; 132(36):1656-60. PubMed ID: 3050555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
